BioNTech SE (BNTX)
90.94
-2.41
(-2.58%)
USD |
NASDAQ |
May 07, 13:14
BioNTech Price to Book Value: 0.9792 for May 7, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 1.005 |
| May 03, 2024 | 0.9984 |
| May 02, 2024 | 0.9933 |
| May 01, 2024 | 0.9686 |
| April 30, 2024 | 0.9564 |
| April 29, 2024 | 0.9471 |
| April 26, 2024 | 0.9391 |
| April 25, 2024 | 0.9337 |
| April 24, 2024 | 0.9486 |
| April 23, 2024 | 0.9529 |
| April 22, 2024 | 0.9477 |
| April 19, 2024 | 0.9348 |
| April 18, 2024 | 0.9279 |
| April 17, 2024 | 0.9304 |
| April 16, 2024 | 0.9297 |
| April 15, 2024 | 0.9464 |
| April 12, 2024 | 0.9312 |
| April 11, 2024 | 0.9369 |
| April 10, 2024 | 0.9546 |
| April 09, 2024 | 0.9697 |
| April 08, 2024 | 0.9617 |
| April 05, 2024 | 0.9615 |
| April 04, 2024 | 0.9554 |
| April 03, 2024 | 0.9643 |
| April 02, 2024 | 0.9723 |
| Date | Value |
|---|---|
| April 01, 2024 | 0.9892 |
| March 28, 2024 | 0.9799 |
| March 27, 2024 | 0.9876 |
| March 26, 2024 | 0.9741 |
| March 25, 2024 | 0.9879 |
| March 22, 2024 | 0.9754 |
| March 21, 2024 | 0.9771 |
| March 20, 2024 | 0.956 |
| March 19, 2024 | 0.9998 |
| March 18, 2024 | 0.9878 |
| March 15, 2024 | 0.9824 |
| March 14, 2024 | 0.9869 |
| March 13, 2024 | 0.998 |
| March 12, 2024 | 1.017 |
| March 11, 2024 | 1.023 |
| March 08, 2024 | 0.9695 |
| March 07, 2024 | 0.9676 |
| March 06, 2024 | 0.9708 |
| March 05, 2024 | 0.9615 |
| March 04, 2024 | 0.9486 |
| March 01, 2024 | 0.966 |
| February 29, 2024 | 0.945 |
| February 28, 2024 | 0.9712 |
| February 27, 2024 | 0.9856 |
| February 26, 2024 | 0.9934 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9279
Minimum
Apr 18 2024
37.74
Maximum
Mar 18 2020
8.772
Average
3.180
Median
Feb 04 2022
Price to Book Value Benchmarks
| Pfizer Inc | 1.779 |
| Moderna Inc | 3.570 |
| Autolus Therapeutics PLC | 9.673 |
| Novavax Inc | -- |
| BioVie Inc | 2.572 |
Price to Book Value Related Metrics
| PE Ratio | 22.15 |
| PS Ratio | 5.328 |
| Price to Free Cash Flow | 4.348 |
| Price | 90.94 |
| Earnings Yield | 4.51% |
| Market Cap | 21.92B |
| Operating PE Ratio | 22.74 |
| Normalized PE Ratio | 19.93 |